Literature DB >> 15709022

Immune tolerance split between hepatitis B virus precore and core proteins.

Margaret Chen1, Matti Sällberg, Janice Hughes, Joyce Jones, Luca G Guidotti, Francis V Chisari, Jean-Noel Billaud, David R Milich.   

Abstract

The function of the hepatitis B virus (HBV) precore or HBeAg is largely unknown because it is not required for viral assembly, infection, or replication. However, the HBeAg does appear to play a role in viral persistence. It has been suggested that the HBeAg may promote HBV chronicity by functioning as an immunoregulatory protein. As a model of chronic HBeAg exposure and to examine the tolerogenic potential of the HBV precore and core (HBcAg) proteins, HBc/HBeAg-transgenic (Tg) mice crossed with T cell receptor (TCR)-Tg mice expressing receptors for the HBc/HBeAgs (i.e., TCR-antigen double-Tg pairs) were produced. This study revealed three phenotypes of HBe/HBcAg-specific T-cell tolerance: (i) profound T-cell tolerance most likely mediated by clonal deletion, (ii) T-cell clonal ignorance, and (iii) nondeletional T-cell tolerance mediated by clonal anergy and dependent on the structure, location, and concentration of the tolerogen. The secreted HBeAg is significantly more efficient than the intracellular HBcAg at eliciting T-cell tolerance. The split T-cell tolerance between the HBeAg and the HBcAg and the clonal heterogeneity of HBc/HBeAg-specific T-cell tolerance may have significant implications for natural HBV infection and especially for precore-negative chronic hepatitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15709022      PMCID: PMC548461          DOI: 10.1128/JVI.79.5.3016-3027.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis.

Authors:  T J Liang; K Hasegawa; N Rimon; J R Wands; E Ben-Porath
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

2.  Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

Authors:  W F Carman; M R Jacyna; S Hadziyannis; P Karayiannis; M J McGarvey; A Makris; H C Thomas
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

3.  Comparative immunogenicity of hepatitis B virus core and E antigens.

Authors:  D R Milich; A McLachlan; S Stahl; P Wingfield; G B Thornton; J L Hughes; J E Jones
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

4.  Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences.

Authors:  A McLachlan; D R Milich; A K Raney; M G Riggs; J L Hughes; J Sorge; F V Chisari
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

5.  Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

Authors:  D R Milich; J E Jones; J L Hughes; J Price; A K Raney; A McLachlan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction.

Authors:  D R Milich; J E Jones; A McLachlan; R Houghten; G B Thornton; J L Hughes
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

7.  Expression of the precore region of an avian hepatitis B virus is not required for viral replication.

Authors:  C Chang; G Enders; R Sprengel; N Peters; H E Varmus; D Ganem
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

8.  Hepatitis B virus mutants with precore-region defects in two babies with fulminant hepatitis and their mothers positive for antibody to hepatitis B e antigen.

Authors:  S Terazawa; M Kojima; T Yamanaka; S Yotsumoto; H Okamoto; F Tsuda; Y Miyakawa; M Mayumi
Journal:  Pediatr Res       Date:  1991-01       Impact factor: 3.756

9.  The hepatitis B virus e antigen cannot pass the murine placenta efficiently and does not induce CTL immune tolerance in H-2b mice in utero.

Authors:  K Reifenberg; T Deutschle; J Wild; R Hanano; I Gastrock-Balitsch; R Schirmbeck; H J Schlicht
Journal:  Virology       Date:  1998-03-30       Impact factor: 3.616

10.  The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation.

Authors:  H J Schlicht; J Salfeld; H Schaller
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

View more
  80 in total

Review 1.  The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Med Microbiol Immunol       Date:  2010-05-11       Impact factor: 3.402

2.  Identification of a unique double-negative regulatory T-cell population.

Authors:  Byung O Lee; Joyce E Jones; Cory J Peters; David Whitacre; Lars Frelin; Janice Hughes; Won-Keun Kim; David R Milich
Journal:  Immunology       Date:  2011-12       Impact factor: 7.397

Review 3.  Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells.

Authors:  Barbara Rehermann
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

4.  Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.

Authors:  Yuan Wang; Lei Cui; Guifang Yang; Jianbo Zhan; Liang Guo; Yu Chen; Chengpeng Fan; Dan Liu; Deyin Guo
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

5.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

Review 6.  Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.

Authors:  Maura Dandri; Joerg Petersen
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079

7.  Molecular mechanisms of HBeAg in persistent HBV infection.

Authors:  Li-Min Chen; Xue-Gong Fan; Jing Ma; Bo He; Yong-Fang Jiang
Journal:  Hepatol Int       Date:  2016-05-18       Impact factor: 6.047

8.  Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B.

Authors:  Jing You; Hutcha Sriplung; Alan Geater; Virasakdi Chongsuvivatwong; Lin Zhuang; Hong-Ying Chen; Lan Yu; Bao-Zhang Tang; Jun-Hua Huang
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

Review 9.  Chronic hepatitis B in children and adolescents: epidemiology and management.

Authors:  Mona Abdel-Hady; Deirdre Kelly
Journal:  Paediatr Drugs       Date:  2013-08       Impact factor: 3.022

Review 10.  Complement and its role in protection and pathogenesis of flavivirus infections.

Authors:  Panisadee Avirutnan; Erin Mehlhop; Michael S Diamond
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.